Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TriSalus Life Sciences (TLSI) Operating Expenses (2022 - 2025)

Historic Operating Expenses for TriSalus Life Sciences (TLSI) over the last 4 years, with Q3 2025 value amounting to $11.8 million.

  • TriSalus Life Sciences' Operating Expenses rose 3229.38% to $11.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.3 million, marking a year-over-year decrease of 1081.97%. This contributed to the annual value of $35.7 million for FY2024, which is 3316.59% down from last year.
  • Latest data reveals that TriSalus Life Sciences reported Operating Expenses of $11.8 million as of Q3 2025, which was up 3229.38% from $9.6 million recorded in Q2 2025.
  • In the past 5 years, TriSalus Life Sciences' Operating Expenses ranged from a high of $18.5 million in Q3 2023 and a low of $288273.0 during Q2 2022
  • Moreover, its 4-year median value for Operating Expenses was $9.2 million (2023), whereas its average is $9.2 million.
  • Per our database at Business Quant, TriSalus Life Sciences' Operating Expenses surged by 398709.8% in 2023 and then plummeted by 5172.41% in 2024.
  • Over the past 4 years, TriSalus Life Sciences' Operating Expenses (Quarter) stood at $10.3 million in 2022, then surged by 33.49% to $13.8 million in 2023, then plummeted by 44.75% to $7.6 million in 2024, then skyrocketed by 55.42% to $11.8 million in 2025.
  • Its Operating Expenses stands at $11.8 million for Q3 2025, versus $9.6 million for Q2 2025 and $8.3 million for Q1 2025.